Caution advised over psychedelic therapies

Research on incorporation of substances such as LSD in treatment of mental illness is in its infancy, experts say

Psychedelic therapies might benefit certain patients with mental illness, but research to date is insufficient to inform clinical practice, leading psychiatrists say.

In a clinical memorandum on the therapeutic use of psychedelic substances, the Royal Australian and New Zealand College of Psychiatrists has cautioned the evidence for their effectiveness and safety is limited.

Psychiatrist Professor David Castle, from St Vincent’s Health and the University of Melbourne, said some clinical trials had